Niue
Reimbursed Care Access
Niue, a small self-governing state in free association with New Zealand, implements international drug-control obligations and in practice has no authorised, reimbursed medical programs for classical psychedelic medicines. Routine medical availability is limited to standard essential medicines (for example ketamine as an anaesthetic) used in the health service; novel psychedelic therapies (psilocybin, MDMA, DMT, 5‑MeO‑DMT, ibogaine, ayahuasca, mescaline, 2C‑X) have no authorised medical/reimbursement pathways in Niue outside of tightly controlled research or international programmes. International treaty obligations and Niue’s participation in multilateral frameworks inform domestic controls. [https://www.who.int/niue/our-work|WHO: Niue country page] [https://www.opcw.org/about-us/member-states/niue|OPCW: Niue membership] [https://en.wikipedia.org/wiki/Convention_on_Psychotropic_Substances|Convention on Psychotropic Substances overview].
No clinical trials found for this country yet.